Make a Wish Foundation Supports Kids With Cancer

If you know of a child with cancer, or you wish to support an organization that cares for those who do, consider Make a Wish Foundation.
You are probably already familiar with it. The Make-A-Wish Foundation is celebrating its 30th anniversary this year. The largest wishgranting nonprofit organization in the world was founded in Phoenix, Ariz., in 1980. The Make-A-Wish Foundation has granted the wishes of more than 188,000 children with life-threatening medical conditions nationwide since its inception.

Typically, children’s wishes fall into four categories: To Be (e.g., a zookeeper, a firefighter, a baker), To Meet (e.g., a favorite celebrity or athlete), To Have (e.g., a computer, a playhouse, a puppy), or To Go (e.g., to a theme park, Hawaii, a major sporting event). To qualify for a wish, the child must be older than 2½ years old and younger than 18 (at the time of referral) and must not have received a wish from another wish-granting organization. A child can be referred to the Make-A-Wish Foundation by a parent or guardian, a medical professional, or by the child.

If you have some Kleenex® handy, read stories about wish kids and what their experiences were like when their wishes came true.

Consider how you can support their important work.
Call (602) 279-9474 or 1-800-722-WISH
wish.org

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap